Search

Search results

1. Easy access to new prescription drugs depends on where you live

   Appeared in the National Post Question: Should patients in Rome or Detroit have faster access to new prescription drugs than someone living in Victoria or Windsor? If your answer to that is no, then here is another query: Why do government agencies tasked ...

2. Access Delayed, Access Denied: Waiting for New Medicines in Canada: 2012

   This edition of Access Delayed, Access Denied is the Fraser Institute?s sixth annual report measuring delays in the approval of new drugs by Health Canada and rates of coverage for new drugs under provincial public drug plans, relative to private-sector ...

3. Access Delayed, Access Denied: Waiting for New Medicines in Canada 2011

   This report focuses on new patented medicines because this class of drugs is uniquely affected by public policies that delay access for patients. Because government approval of generic drugs is based on the assumption that generics are copies of new drugs ...

4. Access Delayed, Access Denied: Waiting for New Medicines in Canada 2010

   This annual report provides patients with some of the information they need to determine whether the time they wait for access to new medicines in Canada is unnecessarily long, and whether publicly funded and managed drug insurance programs provide ...

5. Access Delayed, Access Denied: Waiting for New Medicines in Canada 2009

   This is the Fraser Institute's third annual report on the amount of time patients must wait to access new medicines in Canada. The 2009 edition of this study uses the most recent data available, covering the years 2004, 2005, 2006, and 2007. https:/ ...

6. Access Delayed, Access Denied: Waiting for New Medicines in Canada 2008

   This is the Fraser Institute's second annual report on the amount of time patients must wait to access new medicines in Canada. The purpose of this report is: (1) to draw attention to the impact that Canadian public policies and institutions have on ...

7. Access Delayed, Access Denied: Waiting for New Medicines in Canada 2007

   This report analyzes the total time patients must wait in Canada to gain access to newly invented pharmaceutical and biological medicines, also known as patented drugs. The purpose of this report is twofold: (1) to draw attention to the impact that ...